Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma

Duygu Sezen & Lilie L. Lin et al. · 2021-03-29

A 73-year-old woman with metastatic vaginal mucosal melanoma that had progressed on ipilimumab and nivolumab experienced clinical and radiographic complete response to dual checkpoint inhibitor immunotherapy given in combination with high-dose plus low-dose radiation. General characteristics and treatment options in this disease are highlighted.
Authors
Duygu Sezen, Roshal R. Patel, Christine Tang, Michaela Onstad, Priyadharsini Nagarajan, Sapna P. Patel, James W. Welsh, Lilie L. Lin
Funding
Cancer Center Support GrantCancer Center Support GrantCancer Center Support GrantCancer Center Support Grant

NCI NIH HHS

P30 CA016672

Varian Medical Systems

P30 CA016672

University of Texas MD Anderson Cancer Center

P30 CA016672

National Cancer Institute

P30 CA016672